Farley Capital’s Amgen AMGN Stock Holding History

Farley Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,090	Closed	-$203K	–	14
2017 Q3	$203K	Buy	+1,090	New	+$193K	0.23%	14

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Farley Capital's AMGN Position: Q4 2017 in Review

Farley Capital sold out of Amgen (AMGN) in Q4 2017, closing a stake of 1,090 shares — an estimated $203K sold.

Farley Capital first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $203K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Farley Capital reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Farley Capital sold 1,090 Amgen shares in Q4 2017, an estimated $203K.
Farley Capital first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
Farley Capital's Amgen position peaked at $203K in Q3 2017.
1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Farley Capital's 13F filing for Q4 2017, filed 13 Feb 2018.